Mead Johnson Nutrition Co. (NYSE:MJN) traded up 1.7% during trading on Wednesday . The company traded as high as $85.45 and last traded at $85.19, with a volume of 1,367,322 shares. The stock had previously closed at $83.75.

A number of equities research analysts recently commented on the stock. Susquehanna reaffirmed a “hold” rating on shares of Mead Johnson Nutrition in a report on Sunday, July 17th. Deutsche Bank AG set a $88.00 price objective on shares of Mead Johnson Nutrition and gave the company a “hold” rating in a research note on Sunday, July 24th. Credit Agricole SA upgraded shares of Mead Johnson Nutrition from an “underperform” rating to an “outperform” rating and set a $96.00 price objective for the company in a research note on Wednesday, August 3rd. JPMorgan Chase & Co. upgraded shares of Mead Johnson Nutrition from a “neutral” rating to an “overweight” rating and set a $105.00 price objective for the company in a research note on Tuesday, July 26th. Finally, Zacks Investment Research lowered shares of Mead Johnson Nutrition from a “buy” rating to a “hold” rating in a research note on Monday, June 13th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company’s stock. Mead Johnson Nutrition has a consensus rating of “Hold” and a consensus target price of $96.00.

The company has a market capitalization of $15.39 billion and a P/E ratio of 31.35. The stock has a 50-day moving average of $88.01 and a 200 day moving average of $84.20.

Mead Johnson Nutrition (NYSE:MJN) last announced its quarterly earnings data on Thursday, July 28th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.10. The firm earned $941.50 million during the quarter, compared to analysts’ expectations of $967.25 million. The company’s revenue for the quarter was down 8.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.76 EPS. Equities research analysts predict that Mead Johnson Nutrition Co. will post $3.52 EPS for the current fiscal year.

In other news, SVP Graciela Monteagudo sold 45,873 shares of the company’s stock in a transaction dated Friday, August 5th. The shares were sold at an average price of $87.64, for a total transaction of $4,020,309.72. Following the completion of the transaction, the senior vice president now owns 13,800 shares of the company’s stock, valued at approximately $1,209,432. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Kimberly A. Casiano sold 710 shares of the company’s stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $89.75, for a total transaction of $63,722.50. Following the transaction, the director now directly owns 7,110 shares of the company’s stock, valued at approximately $638,122.50. The disclosure for this sale can be found here.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.